All Off-label articles
-
BusinessCelgene pays $280m to settle off-label marketing lawsuit
Whistleblower case relating to cancer prescriptions
-
Business
FDA accused of violating drug company’s freedom of speech
Amarin says the regulator is stopping it from giving ‘truthful, not misleading’ information to doctors about its fatty acid drug
-
Business
Novartis accused of ‘derailing’ trials for cheap eye disease drug
BMJ says pharma giant is trying to block access to a drug that would save the NHS millions
-
BusinessMis-selling lands J&J with $2.2bn fine
Company found guilty of promoting three drugs for unapproved uses
-
Business
Big data to sniff out drug marketing fraud
US Food and Drug Administration wants to track promotional spending to spot off-label marketing
-
Business$3bn GSK fine sets new industry record
The fine relates to off label marketing and is the largest payment of its kind ever made by a drug company